Reszka, A A
Merck & Co., Inc., Rahway, NJ, USA (United States)
2 papers on CoChat
Most cited papers
- Verified
M-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase
Glantschnig, H., Fisher, J. E., Wesolowski, G., Rodan, G. A., & Reszka, A. A. (2003) · Cell Death & Differentiation
Bone Metabolism and DiseasesPI3K/AKT/mTOR signaling in cancer
Cited by 350
- Verified
Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis.
Halasy-Nagy, J. M., Rodan, G. A., & Reszka, A. A. (2001) · Bone
Bone Metabolism and DiseasesBone health and treatments
Cited by 190
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free